Pharma Export Boom: Sun Pharma, Dr Reddy's, Cipla — Which Stock Will Capture US Market Growth Post-Trade Deal?

For investors seeking maximum leverage from the trade deal, Dr. Reddy's offers the most compelling risk-reward profile.

from NDTV Profit - Latest https://ift.tt/hW7y4iE
https://ift.tt/Aki5Jcn